MXPA02011018A - Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals. - Google Patents

Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.

Info

Publication number
MXPA02011018A
MXPA02011018A MXPA02011018A MXPA02011018A MXPA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A MX PA02011018 A MXPA02011018 A MX PA02011018A
Authority
MX
Mexico
Prior art keywords
treatment
hypertension
mammals
production
resulting products
Prior art date
Application number
MXPA02011018A
Other languages
Spanish (es)
Inventor
Anand Rao
Original Assignee
Davisco Internat Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/567,283 external-priority patent/US6630320B1/en
Priority claimed from US09/702,068 external-priority patent/US6998259B1/en
Application filed by Davisco Internat Foods Inc filed Critical Davisco Internat Foods Inc
Publication of MXPA02011018A publication Critical patent/MXPA02011018A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. ACE inhibitory activity and antihypertension activity were obtained with a hydrolysate of whey protein isolate prepared with a porcine trypsin.
MXPA02011018A 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals. MXPA02011018A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/567,283 US6630320B1 (en) 2000-05-08 2000-05-08 Treatment of hypertension in mammals with hydrolyzed whey proteins
US09/702,068 US6998259B1 (en) 1999-05-20 2000-10-30 Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
PCT/US2001/014797 WO2001085984A1 (en) 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals

Publications (1)

Publication Number Publication Date
MXPA02011018A true MXPA02011018A (en) 2004-08-19

Family

ID=27074429

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011018A MXPA02011018A (en) 2000-05-08 2001-05-08 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.

Country Status (7)

Country Link
EP (1) EP1287159A4 (en)
JP (1) JP2004519204A (en)
AU (1) AU2001259625A1 (en)
CA (1) CA2415688A1 (en)
MX (1) MXPA02011018A (en)
NZ (1) NZ523036A (en)
WO (1) WO2001085984A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1087668T3 (en) 1998-06-17 2005-01-24 New Zealand Dairy Board Bioactive whey protein hydrolyzate
AU2003242695B2 (en) 2002-07-01 2007-12-06 Unilever Plc Satiety inducing composition
EP1466529A1 (en) * 2003-04-07 2004-10-13 Chr. Hansen A/S Composition with heart rate reducing properties
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
CN1784146A (en) * 2003-05-05 2006-06-07 荷兰联合利华有限公司 Peptides having an ace inhibiting effect
ES2253036B1 (en) 2003-07-31 2007-07-16 Consejo Sup. Investig. Cientificas BIOACTIVE PEPTIDES DERIVED FROM PROTEINS OF THE EGG CLEAR BY ENZYMATIC HYDROLYSIS.
US20070141120A1 (en) * 2003-12-15 2007-06-21 Abrahamse Salomon L Peptide having an ace inhibiting effect
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
NL1026931C2 (en) * 2004-08-31 2006-03-01 Friesland Brands Bv ACE-inhibiting whey hydrolysates.
WO2006024673A1 (en) 2004-09-03 2006-03-09 Chr. Hansen A/S Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
FR2876389B1 (en) * 2004-10-13 2007-05-25 Viridis Sa HYDROLYSATS OF WHITE PROTEINS FROM LUZERNE
ES2319475B1 (en) 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas BIOACTIVE PEPTIDES IDENTIFIED IN ENZYMATIC HYDROLYZES OF LACTEE CASEINS AND PROCEDURE OF OBTAINING.
DE102008032828A1 (en) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophan-containing peptides from alpha-lactalbumin with hypotensive and vasoprotective action for biofunctional foods
RS58436B1 (en) 2013-04-25 2019-04-30 Janssen Vaccines & Prevention Bv Stabilized soluble prefusion rsv f polypeptides
JP6840718B2 (en) 2015-07-07 2021-03-10 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． Stabilized pre-soluble fusion RSV F polypeptide
PL3319633T3 (en) 2015-07-07 2021-04-19 Janssen Vaccines & Prevention B.V. Vaccine against rsv
AU2017248018A1 (en) 2016-04-05 2018-09-27 Janssen Vaccines & Prevention B.V. Vaccine against RSV
LT3439672T (en) 2016-04-05 2021-01-25 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion rsv f protein for use in the prophylaxis of rsv infection
MY194419A (en) 2016-05-30 2022-11-30 Janssen Vaccines & Prevention Bv Stabilized pre-fusion rsv f proteins
US11229692B2 (en) 2017-05-17 2022-01-25 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against RSV infection
WO2018210871A1 (en) 2017-05-17 2018-11-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against rsv infection
KR20200053518A (en) 2017-09-15 2020-05-18 얀센 백신스 앤드 프리벤션 비.브이. Method for safe induction of immunity to RSV

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3091772B2 (en) * 1991-03-12 2000-09-25 カルピス株式会社 Angiotensin converting enzyme inhibiting peptide composition
JP3149199B2 (en) * 1991-03-12 2001-03-26 カルピス株式会社 Angiotensin converting enzyme inhibitory peptide
US5744179A (en) * 1992-11-30 1998-04-28 Morinaga Milk Industry Co., Ltd. Low-phosphorus whey protein, manufacturing method thereof, low-phosphorus purified whey hydrolysate and manufacturing method thereof
JPH06345664A (en) * 1993-06-11 1994-12-20 Takako Tomita New composition for suppressing elevation of blood pressure
JPH1033115A (en) * 1996-07-24 1998-02-10 Nouchikusangiyou Shinko Jigyodan Whey beverage and its production
US5854029A (en) * 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent

Also Published As

Publication number Publication date
NZ523036A (en) 2004-04-30
EP1287159A4 (en) 2005-02-09
WO2001085984A1 (en) 2001-11-15
AU2001259625A1 (en) 2001-11-20
EP1287159A1 (en) 2003-03-05
CA2415688A1 (en) 2001-11-15
JP2004519204A (en) 2004-07-02

Similar Documents

Publication Publication Date Title
MXPA02011018A (en) Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals.
Guo et al. Optimisation of hydrolysis conditions for the production of the angiotensin-I converting enzyme (ACE) inhibitory peptides from whey protein using response surface methodology
WO2008108649A3 (en) Ace-inhibitory peptides from whey and methods for providing the same.
AU5764098A (en) Method for producing a protein hydrolysate
AU2003236689A1 (en) Protein hydrolysate rich in tripeptides
MXPA06001173A (en) Analytical method for pancreatin and comparable compositions.
WO2002060474A3 (en) Mixtures of mushroom enzymes and the use thereof for treating maldigestion
DK1546316T3 (en) Mutant E. coli
CA2188542A1 (en) A method for improving the solubility of vegetable proteins
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
IL139478A0 (en) Hybrid protein
ATE397623T1 (en) ACE-INHIBITING WHEY HYDROLYSATES
IL157414A0 (en) Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
AU2003217325A1 (en) Complex technologies using enzymatic protein hydrolysate
FR2608051B1 (en) PROCESS FOR THE MANUFACTURE OF AN ENZYMATIC HYDROLYSATE OF PROTEINS RICH IN DI- AND TRI-PEPTIDES, FOR USE IN PARTICULAR IN ARTIFICIAL NUTRITION AND DIETETICS
Seok et al. Change of protein and amino acid composition during Chungkook-Jang fermentation using Bacillus licheniformis CN-115
WO2005021762A3 (en) A process for proteolytic cleavage and purification of recombinant proteins produced in plants
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
CA2406607A1 (en) A method of treating soy proteins and a soy protein product produced by this method
WO2003070229A3 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
PL374192A1 (en) Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
AU9066198A (en) Use of bromelain proteases for inhibiting blood coagulation
ATE281522T1 (en) SENTRIN-SPECIFIC HUMAN PROTEASE SENP1
WO2001062066A3 (en) For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture